Well Lead Medical Co., Ltd. (SHA:603309)
China
· Delayed Price · Currency is CNY 11.84
+0.12 (1.02%)
May 7, 2025, 10:45 AM CST
Well Lead Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,548 | 1,509 | 1,366 | 1,354 | 1,106 | 1,121 | Upgrade
|
Other Revenue | - | - | 21.97 | 9.63 | 12.68 | 9.89 | Upgrade
|
| Revenue | 1,548 | 1,509 | 1,388 | 1,363 | 1,119 | 1,131 | Upgrade
|
Revenue Growth (YoY) | 15.95% | 8.76% | 1.79% | 21.88% | -1.07% | 13.77% | Upgrade
|
Cost of Revenue | 865.57 | 837.19 | 762.64 | 784.98 | 646.82 | 637.18 | Upgrade
|
Gross Profit | 682.73 | 672.15 | 625.1 | 578.37 | 471.76 | 493.49 | Upgrade
|
Selling, General & Admin | 287.65 | 288.14 | 292.06 | 286.47 | 255.91 | 204.08 | Upgrade
|
Research & Development | 111.87 | 111.11 | 94.92 | 82.07 | 55.03 | 55.31 | Upgrade
|
Other Operating Expenses | 2.82 | 3.7 | 9.21 | 14.09 | 10.83 | 11.95 | Upgrade
|
Operating Expenses | 402.83 | 402.95 | 396.98 | 381.24 | 322.6 | 273.12 | Upgrade
|
Operating Income | 279.9 | 269.19 | 228.12 | 197.13 | 149.16 | 220.37 | Upgrade
|
Interest Expense | -0.31 | - | -9.12 | -7.87 | -8.49 | -10.43 | Upgrade
|
Interest & Investment Income | 6.05 | 6.69 | 12.2 | 7.53 | 1.38 | 0.9 | Upgrade
|
Currency Exchange Gain (Loss) | - | - | 0.91 | 7.4 | -1.64 | -8.24 | Upgrade
|
Other Non Operating Income (Expenses) | -6.55 | -4.62 | 0.26 | -1.4 | -1.47 | -0.68 | Upgrade
|
EBT Excluding Unusual Items | 279.09 | 271.27 | 232.37 | 202.79 | 138.94 | 201.92 | Upgrade
|
Gain (Loss) on Sale of Investments | 0.81 | 0.62 | 0.08 | 1.94 | -4.84 | -1.79 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.41 | 0.43 | -0.36 | -0.07 | 0 | -2.58 | Upgrade
|
Asset Writedown | -8.47 | -9.27 | - | -7.47 | -0.56 | -9.79 | Upgrade
|
Other Unusual Items | - | - | 5.22 | 8.46 | 6.69 | 2.35 | Upgrade
|
Pretax Income | 271.85 | 263.04 | 237.3 | 205.65 | 140.22 | 190.11 | Upgrade
|
Income Tax Expense | 35.35 | 34.57 | 32.7 | 27.9 | 25.55 | 30.23 | Upgrade
|
Earnings From Continuing Operations | 236.5 | 228.47 | 204.6 | 177.75 | 114.67 | 159.88 | Upgrade
|
Minority Interest in Earnings | -8.44 | -9.08 | -12.12 | -11.18 | -8.58 | -6.77 | Upgrade
|
Net Income | 228.06 | 219.39 | 192.49 | 166.57 | 106.09 | 153.11 | Upgrade
|
Net Income to Common | 228.06 | 219.39 | 192.49 | 166.57 | 106.09 | 153.11 | Upgrade
|
Net Income Growth | 19.63% | 13.98% | 15.56% | 57.00% | -30.71% | 26.39% | Upgrade
|
Shares Outstanding (Basic) | 292 | 293 | 292 | 292 | 259 | 260 | Upgrade
|
Shares Outstanding (Diluted) | 292 | 293 | 292 | 292 | 259 | 260 | Upgrade
|
Shares Change (YoY) | -0.31% | 0.30% | -0.20% | 12.93% | -0.29% | 0.68% | Upgrade
|
EPS (Basic) | 0.78 | 0.75 | 0.66 | 0.57 | 0.41 | 0.59 | Upgrade
|
EPS (Diluted) | 0.78 | 0.75 | 0.66 | 0.57 | 0.41 | 0.59 | Upgrade
|
EPS Growth | 20.00% | 13.64% | 15.79% | 39.02% | -30.51% | 25.53% | Upgrade
|
Free Cash Flow | -13.3 | -9.47 | -135.38 | 209.75 | 78 | 135.96 | Upgrade
|
Free Cash Flow Per Share | -0.05 | -0.03 | -0.46 | 0.72 | 0.30 | 0.52 | Upgrade
|
Dividend Per Share | - | - | 0.500 | 0.340 | 0.135 | 0.200 | Upgrade
|
Dividend Growth | - | - | 47.06% | 151.85% | -32.50% | 30.04% | Upgrade
|
Gross Margin | 44.10% | 44.53% | 45.04% | 42.42% | 42.18% | 43.65% | Upgrade
|
Operating Margin | 18.08% | 17.84% | 16.44% | 14.46% | 13.33% | 19.49% | Upgrade
|
Profit Margin | 14.73% | 14.54% | 13.87% | 12.22% | 9.49% | 13.54% | Upgrade
|
Free Cash Flow Margin | -0.86% | -0.63% | -9.75% | 15.38% | 6.97% | 12.02% | Upgrade
|
EBITDA | 349.57 | 335.69 | 281.92 | 253.46 | 198.48 | 268.92 | Upgrade
|
EBITDA Margin | 22.58% | 22.24% | 20.32% | 18.59% | 17.74% | 23.78% | Upgrade
|
D&A For EBITDA | 69.67 | 66.5 | 53.81 | 56.33 | 49.32 | 48.55 | Upgrade
|
EBIT | 279.9 | 269.19 | 228.12 | 197.13 | 149.16 | 220.37 | Upgrade
|
EBIT Margin | 18.08% | 17.84% | 16.44% | 14.46% | 13.33% | 19.49% | Upgrade
|
Effective Tax Rate | 13.00% | 13.14% | 13.78% | 13.57% | 18.22% | 15.90% | Upgrade
|
Revenue as Reported | 38.97 | - | 1,388 | 1,363 | 1,119 | 1,131 | Upgrade
|
Updated Oct 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.